Results: 28 of 231 patients proved metastatic SLN pathologically. 25 cases of these 28 cases diagnosed as metastasis preoperatively according to the criteria. 13 cases (52%) diagnosed from criteria A, ...

Goldman Sachs initiated Silence Therapeutics (NASDAQ:SLN) with a Sell rating and a $6 price target on Tuesday, arguing that with only about $173M of cash and equivalents at the end of Q3 2024, the ...

To get a sense of who is truly in control of Silence Therapeutics plc (NASDAQ:SLN), it is important to understand the ownership structure of the business. And the group that holds the biggest ...

Wall Street held near its record heights on Monday, ahead of a week likely to be dominated by updates from the head of the Federal Reserve and from some of the biggest U.S. retailers. The S&P 500 ...